ArticleBMC cardiovascular disorders2026
A case report of a giant left atrial myxoma traversing a patent foramen ovale as a biatrial myxoma.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCardiac myxomas are the most common primary cardiac tumors, typically located in the left atrium. A rare and clinically significant variant is the biatrial myxoma, which most commonly extends from the left to the right atrium by traversing a patent foramen ovale (PFO). These tumors can present with a triad of embolic phenomena, obstructive symptoms, and constitutional symptoms, posing a high risk of life-threatening complications.
backgroundCardiac myxomas, though rare benign tumors with an incidence of approximately 0.0017%, represent the most common primary cardiac neoplasm. Biatrial involvement is exceptionally uncommon. This report presents a case of a giant left atrial myxoma traversing a patent foramen ovale (PFO), thereby simulating a true biatrial tumor.
conclusionThis case highlights that a left atrial myxoma traversing a patent foramen ovale can mimic a biatrial tumor on imaging, underscoring the critical need for multimodal assessment to guide complete surgical excision and prevent catastrophic embolic complications. However, the generalizability of this finding is limited by the single-case nature of this report. Ultimately, despite its benign histology, timely and precise resection remains paramount, as it offers an excellent prognosis in most cases and underscores the importance of considering cardiac tumors in the differential diagnosis of unexplained embolic events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.